nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone—CYP1B1—Mitoxantrone—lymphatic system cancer	0.106	0.13	CbGbCtD
Testosterone—SLC22A1—Cytarabine—lymphatic system cancer	0.0864	0.106	CbGbCtD
Testosterone—SLC22A3—Vincristine—lymphatic system cancer	0.0797	0.0975	CbGbCtD
Testosterone—ABCG2—Teniposide—lymphatic system cancer	0.0723	0.0885	CbGbCtD
Testosterone—ABCG2—Mitoxantrone—lymphatic system cancer	0.0506	0.0619	CbGbCtD
Testosterone—SLC22A7—Methotrexate—lymphatic system cancer	0.0401	0.0491	CbGbCtD
Testosterone—CYP3A5—Teniposide—lymphatic system cancer	0.0401	0.049	CbGbCtD
Testosterone—ABCG2—Vincristine—lymphatic system cancer	0.0348	0.0426	CbGbCtD
Testosterone—CYP2C19—Teniposide—lymphatic system cancer	0.0323	0.0396	CbGbCtD
Testosterone—SLCO1A2—Methotrexate—lymphatic system cancer	0.0281	0.0344	CbGbCtD
Testosterone—CYP2C9—Teniposide—lymphatic system cancer	0.0269	0.0329	CbGbCtD
Testosterone—CYP3A7—Vincristine—lymphatic system cancer	0.0257	0.0315	CbGbCtD
Testosterone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0257	0.0315	CbGbCtD
Testosterone—SLC22A8—Methotrexate—lymphatic system cancer	0.0245	0.03	CbGbCtD
Testosterone—ABCG2—Methotrexate—lymphatic system cancer	0.0211	0.0258	CbGbCtD
Testosterone—CYP3A5—Vincristine—lymphatic system cancer	0.0193	0.0236	CbGbCtD
Testosterone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0182	0.0223	CbGbCtD
Testosterone—CYP3A4—Cytarabine—lymphatic system cancer	0.0159	0.0194	CbGbCtD
Testosterone—CYP3A4—Teniposide—lymphatic system cancer	0.0156	0.0191	CbGbCtD
Testosterone—ALB—Methotrexate—lymphatic system cancer	0.0145	0.0178	CbGbCtD
Testosterone—ABCB1—Vincristine—lymphatic system cancer	0.0126	0.0154	CbGbCtD
Testosterone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0109	0.0134	CbGbCtD
Testosterone—ABCB1—Methotrexate—lymphatic system cancer	0.0076	0.0093	CbGbCtD
Testosterone—CYP3A4—Vincristine—lymphatic system cancer	0.00752	0.0092	CbGbCtD
Testosterone—Haematuria—Mitoxantrone—lymphatic system cancer	0.000318	0.00174	CcSEcCtD
Testosterone—Oedema peripheral—Carmustine—lymphatic system cancer	0.000318	0.00174	CcSEcCtD
Testosterone—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000317	0.00173	CcSEcCtD
Testosterone—Ulcer—Methotrexate—lymphatic system cancer	0.000314	0.00172	CcSEcCtD
Testosterone—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000313	0.00171	CcSEcCtD
Testosterone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000309	0.00169	CcSEcCtD
Testosterone—Fatigue—Fludarabine—lymphatic system cancer	0.000308	0.00169	CcSEcCtD
Testosterone—Inflammation—Methotrexate—lymphatic system cancer	0.000306	0.00168	CcSEcCtD
Testosterone—Pain—Fludarabine—lymphatic system cancer	0.000306	0.00168	CcSEcCtD
Testosterone—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000304	0.00166	CcSEcCtD
Testosterone—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000302	0.00166	CcSEcCtD
Testosterone—Urethral disorder—Vincristine—lymphatic system cancer	0.000302	0.00165	CcSEcCtD
Testosterone—Eye disorder—Carmustine—lymphatic system cancer	0.000301	0.00165	CcSEcCtD
Testosterone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000301	0.00165	CcSEcCtD
Testosterone—Rhinitis—Mitoxantrone—lymphatic system cancer	0.0003	0.00165	CcSEcCtD
Testosterone—Hypersensitivity—Teniposide—lymphatic system cancer	0.0003	0.00164	CcSEcCtD
Testosterone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.0003	0.00164	CcSEcCtD
Testosterone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000298	0.00163	CcSEcCtD
Testosterone—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.000297	0.00163	CcSEcCtD
Testosterone—Anaemia—Bleomycin—lymphatic system cancer	0.000297	0.00163	CcSEcCtD
Testosterone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000295	0.00161	CcSEcCtD
Testosterone—Asthenia—Teniposide—lymphatic system cancer	0.000292	0.0016	CcSEcCtD
Testosterone—Malaise—Bleomycin—lymphatic system cancer	0.00029	0.00159	CcSEcCtD
Testosterone—Pruritus—Teniposide—lymphatic system cancer	0.000288	0.00158	CcSEcCtD
Testosterone—Cardiac disorder—Vincristine—lymphatic system cancer	0.000286	0.00156	CcSEcCtD
Testosterone—Alopecia—Carmustine—lymphatic system cancer	0.000285	0.00156	CcSEcCtD
Testosterone—Mental disorder—Carmustine—lymphatic system cancer	0.000282	0.00155	CcSEcCtD
Testosterone—Erythema—Carmustine—lymphatic system cancer	0.000281	0.00154	CcSEcCtD
Testosterone—Malnutrition—Carmustine—lymphatic system cancer	0.000281	0.00154	CcSEcCtD
Testosterone—Cough—Bleomycin—lymphatic system cancer	0.00028	0.00154	CcSEcCtD
Testosterone—Angiopathy—Vincristine—lymphatic system cancer	0.000279	0.00153	CcSEcCtD
Testosterone—Diarrhoea—Teniposide—lymphatic system cancer	0.000279	0.00153	CcSEcCtD
Testosterone—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000277	0.00152	CcSEcCtD
Testosterone—Chest pain—Bleomycin—lymphatic system cancer	0.000274	0.0015	CcSEcCtD
Testosterone—Myalgia—Bleomycin—lymphatic system cancer	0.000274	0.0015	CcSEcCtD
Testosterone—Alopecia—Vincristine—lymphatic system cancer	0.000272	0.00149	CcSEcCtD
Testosterone—Back pain—Carmustine—lymphatic system cancer	0.000271	0.00149	CcSEcCtD
Testosterone—Discomfort—Bleomycin—lymphatic system cancer	0.00027	0.00148	CcSEcCtD
Testosterone—Mental disorder—Vincristine—lymphatic system cancer	0.00027	0.00148	CcSEcCtD
Testosterone—Chills—Mitoxantrone—lymphatic system cancer	0.000269	0.00147	CcSEcCtD
Testosterone—Neoplasm—Methotrexate—lymphatic system cancer	0.000269	0.00147	CcSEcCtD
Testosterone—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000269	0.00147	CcSEcCtD
Testosterone—Urine output increased—Methotrexate—lymphatic system cancer	0.000269	0.00147	CcSEcCtD
Testosterone—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000266	0.00146	CcSEcCtD
Testosterone—Alopecia—Mitoxantrone—lymphatic system cancer	0.000265	0.00145	CcSEcCtD
Testosterone—Confusional state—Bleomycin—lymphatic system cancer	0.000265	0.00145	CcSEcCtD
Testosterone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000264	0.00144	CcSEcCtD
Testosterone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000262	0.00144	CcSEcCtD
Testosterone—Oedema—Bleomycin—lymphatic system cancer	0.000262	0.00144	CcSEcCtD
Testosterone—Erythema—Mitoxantrone—lymphatic system cancer	0.000261	0.00143	CcSEcCtD
Testosterone—Infection—Bleomycin—lymphatic system cancer	0.000261	0.00143	CcSEcCtD
Testosterone—Anaemia—Carmustine—lymphatic system cancer	0.000259	0.00142	CcSEcCtD
Testosterone—Back pain—Vincristine—lymphatic system cancer	0.000259	0.00142	CcSEcCtD
Testosterone—Vomiting—Teniposide—lymphatic system cancer	0.000259	0.00142	CcSEcCtD
Testosterone—Agitation—Carmustine—lymphatic system cancer	0.000258	0.00141	CcSEcCtD
Testosterone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000257	0.00141	CcSEcCtD
Testosterone—Asthenia—Fludarabine—lymphatic system cancer	0.000257	0.00141	CcSEcCtD
Testosterone—Rash—Teniposide—lymphatic system cancer	0.000257	0.00141	CcSEcCtD
Testosterone—Dermatitis—Teniposide—lymphatic system cancer	0.000256	0.0014	CcSEcCtD
Testosterone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000255	0.0014	CcSEcCtD
Testosterone—Headache—Teniposide—lymphatic system cancer	0.000255	0.0014	CcSEcCtD
Testosterone—Pruritus—Fludarabine—lymphatic system cancer	0.000253	0.00139	CcSEcCtD
Testosterone—Back pain—Mitoxantrone—lymphatic system cancer	0.000252	0.00138	CcSEcCtD
Testosterone—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000248	0.00136	CcSEcCtD
Testosterone—Anaemia—Vincristine—lymphatic system cancer	0.000248	0.00136	CcSEcCtD
Testosterone—Agitation—Vincristine—lymphatic system cancer	0.000246	0.00135	CcSEcCtD
Testosterone—Polyuria—Methotrexate—lymphatic system cancer	0.000246	0.00135	CcSEcCtD
Testosterone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000245	0.00134	CcSEcCtD
Testosterone—Hypertension—Carmustine—lymphatic system cancer	0.000242	0.00133	CcSEcCtD
Testosterone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000242	0.00133	CcSEcCtD
Testosterone—Nausea—Teniposide—lymphatic system cancer	0.000242	0.00132	CcSEcCtD
Testosterone—Anaemia—Mitoxantrone—lymphatic system cancer	0.000241	0.00132	CcSEcCtD
Testosterone—Vertigo—Vincristine—lymphatic system cancer	0.000241	0.00132	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000239	0.00131	CcSEcCtD
Testosterone—Chest pain—Carmustine—lymphatic system cancer	0.000239	0.00131	CcSEcCtD
Testosterone—Myalgia—Carmustine—lymphatic system cancer	0.000239	0.00131	CcSEcCtD
Testosterone—Anxiety—Carmustine—lymphatic system cancer	0.000238	0.0013	CcSEcCtD
Testosterone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000236	0.00129	CcSEcCtD
Testosterone—Malaise—Mitoxantrone—lymphatic system cancer	0.000235	0.00129	CcSEcCtD
Testosterone—Dyspnoea—Bleomycin—lymphatic system cancer	0.000234	0.00128	CcSEcCtD
Testosterone—Hypertension—Vincristine—lymphatic system cancer	0.000231	0.00127	CcSEcCtD
Testosterone—Confusional state—Carmustine—lymphatic system cancer	0.000231	0.00126	CcSEcCtD
Testosterone—Oedema—Carmustine—lymphatic system cancer	0.000229	0.00125	CcSEcCtD
Testosterone—Myalgia—Vincristine—lymphatic system cancer	0.000228	0.00125	CcSEcCtD
Testosterone—Cough—Mitoxantrone—lymphatic system cancer	0.000228	0.00125	CcSEcCtD
Testosterone—Infection—Carmustine—lymphatic system cancer	0.000227	0.00125	CcSEcCtD
Testosterone—Vomiting—Fludarabine—lymphatic system cancer	0.000227	0.00125	CcSEcCtD
Testosterone—Rash—Fludarabine—lymphatic system cancer	0.000226	0.00124	CcSEcCtD
Testosterone—Dermatitis—Fludarabine—lymphatic system cancer	0.000225	0.00123	CcSEcCtD
Testosterone—Hypertension—Mitoxantrone—lymphatic system cancer	0.000225	0.00123	CcSEcCtD
Testosterone—Pain—Bleomycin—lymphatic system cancer	0.000224	0.00123	CcSEcCtD
Testosterone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000224	0.00123	CcSEcCtD
Testosterone—Headache—Fludarabine—lymphatic system cancer	0.000224	0.00123	CcSEcCtD
Testosterone—Tachycardia—Carmustine—lymphatic system cancer	0.000223	0.00122	CcSEcCtD
Testosterone—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000223	0.00122	CcSEcCtD
Testosterone—Chest pain—Mitoxantrone—lymphatic system cancer	0.000222	0.00122	CcSEcCtD
Testosterone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000222	0.00122	CcSEcCtD
Testosterone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000222	0.00122	CcSEcCtD
Testosterone—Anxiety—Mitoxantrone—lymphatic system cancer	0.000221	0.00121	CcSEcCtD
Testosterone—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00022	0.00121	CcSEcCtD
Testosterone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000219	0.0012	CcSEcCtD
Testosterone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000219	0.0012	CcSEcCtD
Testosterone—Oedema—Vincristine—lymphatic system cancer	0.000219	0.0012	CcSEcCtD
Testosterone—Infection—Vincristine—lymphatic system cancer	0.000217	0.00119	CcSEcCtD
Testosterone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000216	0.00118	CcSEcCtD
Testosterone—Confusional state—Mitoxantrone—lymphatic system cancer	0.000215	0.00118	CcSEcCtD
Testosterone—Nervous system disorder—Vincristine—lymphatic system cancer	0.000214	0.00117	CcSEcCtD
Testosterone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000214	0.00117	CcSEcCtD
Testosterone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000213	0.00117	CcSEcCtD
Testosterone—Oedema—Mitoxantrone—lymphatic system cancer	0.000213	0.00117	CcSEcCtD
Testosterone—Nausea—Fludarabine—lymphatic system cancer	0.000213	0.00116	CcSEcCtD
Testosterone—Infection—Mitoxantrone—lymphatic system cancer	0.000211	0.00116	CcSEcCtD
Testosterone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000211	0.00116	CcSEcCtD
Testosterone—Shock—Mitoxantrone—lymphatic system cancer	0.000209	0.00115	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000209	0.00114	CcSEcCtD
Testosterone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000208	0.00114	CcSEcCtD
Testosterone—Urticaria—Bleomycin—lymphatic system cancer	0.000208	0.00114	CcSEcCtD
Testosterone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000208	0.00114	CcSEcCtD
Testosterone—Insomnia—Carmustine—lymphatic system cancer	0.000207	0.00113	CcSEcCtD
Testosterone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000207	0.00113	CcSEcCtD
Testosterone—Irritability—Methotrexate—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Testosterone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Testosterone—Paraesthesia—Carmustine—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Testosterone—Mood swings—Methotrexate—lymphatic system cancer	0.000204	0.00112	CcSEcCtD
Testosterone—Dyspnoea—Carmustine—lymphatic system cancer	0.000204	0.00112	CcSEcCtD
Testosterone—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000199	0.00109	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000199	0.00109	CcSEcCtD
Testosterone—Insomnia—Vincristine—lymphatic system cancer	0.000198	0.00108	CcSEcCtD
Testosterone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000198	0.00108	CcSEcCtD
Testosterone—Paraesthesia—Vincristine—lymphatic system cancer	0.000196	0.00107	CcSEcCtD
Testosterone—Pain—Carmustine—lymphatic system cancer	0.000196	0.00107	CcSEcCtD
Testosterone—Breast disorder—Methotrexate—lymphatic system cancer	0.000195	0.00107	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000194	0.00106	CcSEcCtD
Testosterone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000193	0.00106	CcSEcCtD
Testosterone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000191	0.00105	CcSEcCtD
Testosterone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00019	0.00104	CcSEcCtD
Testosterone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000189	0.00103	CcSEcCtD
Testosterone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000189	0.00103	CcSEcCtD
Testosterone—Fatigue—Vincristine—lymphatic system cancer	0.000188	0.00103	CcSEcCtD
Testosterone—Asthenia—Bleomycin—lymphatic system cancer	0.000188	0.00103	CcSEcCtD
Testosterone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000187	0.00103	CcSEcCtD
Testosterone—Pain—Vincristine—lymphatic system cancer	0.000187	0.00102	CcSEcCtD
Testosterone—Asthma—Methotrexate—lymphatic system cancer	0.000187	0.00102	CcSEcCtD
Testosterone—Pruritus—Bleomycin—lymphatic system cancer	0.000186	0.00102	CcSEcCtD
Testosterone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000184	0.00101	CcSEcCtD
Testosterone—Pain—Mitoxantrone—lymphatic system cancer	0.000182	0.000997	CcSEcCtD
Testosterone—Abdominal pain—Carmustine—lymphatic system cancer	0.000181	0.000991	CcSEcCtD
Testosterone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000179	0.000979	CcSEcCtD
Testosterone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000175	0.000961	CcSEcCtD
Testosterone—Dysuria—Methotrexate—lymphatic system cancer	0.000174	0.000955	CcSEcCtD
Testosterone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000174	0.000953	CcSEcCtD
Testosterone—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000173	0.000949	CcSEcCtD
Testosterone—Abdominal pain—Vincristine—lymphatic system cancer	0.000173	0.000946	CcSEcCtD
Testosterone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000172	0.000941	CcSEcCtD
Testosterone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000169	0.000926	CcSEcCtD
Testosterone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000169	0.000924	CcSEcCtD
Testosterone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000168	0.000922	CcSEcCtD
Testosterone—Pneumonia—Methotrexate—lymphatic system cancer	0.000167	0.000916	CcSEcCtD
Testosterone—Vomiting—Bleomycin—lymphatic system cancer	0.000167	0.000913	CcSEcCtD
Testosterone—Infestation—Methotrexate—lymphatic system cancer	0.000166	0.000911	CcSEcCtD
Testosterone—Infestation NOS—Methotrexate—lymphatic system cancer	0.000166	0.000911	CcSEcCtD
Testosterone—Depression—Methotrexate—lymphatic system cancer	0.000166	0.000908	CcSEcCtD
Testosterone—Rash—Bleomycin—lymphatic system cancer	0.000165	0.000906	CcSEcCtD
Testosterone—Dermatitis—Bleomycin—lymphatic system cancer	0.000165	0.000905	CcSEcCtD
Testosterone—Asthenia—Carmustine—lymphatic system cancer	0.000164	0.0009	CcSEcCtD
Testosterone—Renal failure—Methotrexate—lymphatic system cancer	0.000163	0.000895	CcSEcCtD
Testosterone—Stomatitis—Methotrexate—lymphatic system cancer	0.000162	0.000888	CcSEcCtD
Testosterone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000161	0.000882	CcSEcCtD
Testosterone—Sweating—Methotrexate—lymphatic system cancer	0.000159	0.000873	CcSEcCtD
Testosterone—Haematuria—Methotrexate—lymphatic system cancer	0.000159	0.000868	CcSEcCtD
Testosterone—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000157	0.000861	CcSEcCtD
Testosterone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000157	0.000859	CcSEcCtD
Testosterone—Asthenia—Vincristine—lymphatic system cancer	0.000157	0.000859	CcSEcCtD
Testosterone—Diarrhoea—Carmustine—lymphatic system cancer	0.000157	0.000858	CcSEcCtD
Testosterone—Nausea—Bleomycin—lymphatic system cancer	0.000156	0.000853	CcSEcCtD
Testosterone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000153	0.000836	CcSEcCtD
Testosterone—Dizziness—Carmustine—lymphatic system cancer	0.000151	0.000829	CcSEcCtD
Testosterone—Haemoglobin—Methotrexate—lymphatic system cancer	0.00015	0.000822	CcSEcCtD
Testosterone—Diarrhoea—Vincristine—lymphatic system cancer	0.00015	0.000819	CcSEcCtD
Testosterone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000149	0.000818	CcSEcCtD
Testosterone—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000147	0.000807	CcSEcCtD
Testosterone—Urethral disorder—Methotrexate—lymphatic system cancer	0.000146	0.000801	CcSEcCtD
Testosterone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000146	0.000798	CcSEcCtD
Testosterone—Vomiting—Carmustine—lymphatic system cancer	0.000146	0.000797	CcSEcCtD
Testosterone—Dizziness—Vincristine—lymphatic system cancer	0.000145	0.000792	CcSEcCtD
Testosterone—Rash—Carmustine—lymphatic system cancer	0.000144	0.000791	CcSEcCtD
Testosterone—Dermatitis—Carmustine—lymphatic system cancer	0.000144	0.00079	CcSEcCtD
Testosterone—Headache—Carmustine—lymphatic system cancer	0.000143	0.000786	CcSEcCtD
Testosterone—Eye disorder—Methotrexate—lymphatic system cancer	0.00014	0.000764	CcSEcCtD
Testosterone—Tinnitus—Methotrexate—lymphatic system cancer	0.000139	0.000762	CcSEcCtD
Testosterone—Vomiting—Vincristine—lymphatic system cancer	0.000139	0.000761	CcSEcCtD
Testosterone—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000139	0.000759	CcSEcCtD
Testosterone—Rash—Vincristine—lymphatic system cancer	0.000138	0.000755	CcSEcCtD
Testosterone—Dermatitis—Vincristine—lymphatic system cancer	0.000138	0.000754	CcSEcCtD
Testosterone—Headache—Vincristine—lymphatic system cancer	0.000137	0.00075	CcSEcCtD
Testosterone—Nausea—Carmustine—lymphatic system cancer	0.000136	0.000745	CcSEcCtD
Testosterone—Angiopathy—Methotrexate—lymphatic system cancer	0.000135	0.000742	CcSEcCtD
Testosterone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000135	0.000741	CcSEcCtD
Testosterone—Immune system disorder—Methotrexate—lymphatic system cancer	0.000135	0.000738	CcSEcCtD
Testosterone—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000135	0.000737	CcSEcCtD
Testosterone—Rash—Mitoxantrone—lymphatic system cancer	0.000134	0.000735	CcSEcCtD
Testosterone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000134	0.000734	CcSEcCtD
Testosterone—Chills—Methotrexate—lymphatic system cancer	0.000134	0.000734	CcSEcCtD
Testosterone—Headache—Mitoxantrone—lymphatic system cancer	0.000133	0.00073	CcSEcCtD
Testosterone—Alopecia—Methotrexate—lymphatic system cancer	0.000132	0.000722	CcSEcCtD
Testosterone—Mental disorder—Methotrexate—lymphatic system cancer	0.000131	0.000716	CcSEcCtD
Testosterone—Erythema—Methotrexate—lymphatic system cancer	0.00013	0.000712	CcSEcCtD
Testosterone—Malnutrition—Methotrexate—lymphatic system cancer	0.00013	0.000712	CcSEcCtD
Testosterone—Nausea—Vincristine—lymphatic system cancer	0.00013	0.000711	CcSEcCtD
Testosterone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000127	0.000697	CcSEcCtD
Testosterone—Nausea—Mitoxantrone—lymphatic system cancer	0.000126	0.000693	CcSEcCtD
Testosterone—Back pain—Methotrexate—lymphatic system cancer	0.000126	0.000688	CcSEcCtD
Testosterone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000121	0.00066	CcSEcCtD
Testosterone—Anaemia—Methotrexate—lymphatic system cancer	0.00012	0.000658	CcSEcCtD
Testosterone—Malaise—Methotrexate—lymphatic system cancer	0.000117	0.000642	CcSEcCtD
Testosterone—Vertigo—Methotrexate—lymphatic system cancer	0.000117	0.000639	CcSEcCtD
Testosterone—Cough—Methotrexate—lymphatic system cancer	0.000113	0.000621	CcSEcCtD
Testosterone—Chest pain—Methotrexate—lymphatic system cancer	0.000111	0.000606	CcSEcCtD
Testosterone—Myalgia—Methotrexate—lymphatic system cancer	0.000111	0.000606	CcSEcCtD
Testosterone—Arthralgia—Methotrexate—lymphatic system cancer	0.000111	0.000606	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00011	0.000602	CcSEcCtD
Testosterone—Discomfort—Methotrexate—lymphatic system cancer	0.000109	0.000599	CcSEcCtD
Testosterone—Confusional state—Methotrexate—lymphatic system cancer	0.000107	0.000586	CcSEcCtD
Testosterone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000106	0.000581	CcSEcCtD
Testosterone—Infection—Methotrexate—lymphatic system cancer	0.000105	0.000577	CcSEcCtD
Testosterone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000104	0.00057	CcSEcCtD
Testosterone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000104	0.000569	CcSEcCtD
Testosterone—Skin disorder—Methotrexate—lymphatic system cancer	0.000103	0.000564	CcSEcCtD
Testosterone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000103	0.000562	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	9.66e-05	0.000529	CcSEcCtD
Testosterone—Insomnia—Methotrexate—lymphatic system cancer	9.59e-05	0.000525	CcSEcCtD
Testosterone—Paraesthesia—Methotrexate—lymphatic system cancer	9.52e-05	0.000522	CcSEcCtD
Testosterone—Dyspnoea—Methotrexate—lymphatic system cancer	9.46e-05	0.000518	CcSEcCtD
Testosterone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	9.16e-05	0.000501	CcSEcCtD
Testosterone—Fatigue—Methotrexate—lymphatic system cancer	9.14e-05	0.000501	CcSEcCtD
Testosterone—Pain—Methotrexate—lymphatic system cancer	9.07e-05	0.000497	CcSEcCtD
Testosterone—Feeling abnormal—Methotrexate—lymphatic system cancer	8.74e-05	0.000479	CcSEcCtD
Testosterone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	8.67e-05	0.000475	CcSEcCtD
Testosterone—Urticaria—Methotrexate—lymphatic system cancer	8.43e-05	0.000461	CcSEcCtD
Testosterone—Abdominal pain—Methotrexate—lymphatic system cancer	8.38e-05	0.000459	CcSEcCtD
Testosterone—Hypersensitivity—Methotrexate—lymphatic system cancer	7.81e-05	0.000428	CcSEcCtD
Testosterone—Asthenia—Methotrexate—lymphatic system cancer	7.61e-05	0.000417	CcSEcCtD
Testosterone—Pruritus—Methotrexate—lymphatic system cancer	7.5e-05	0.000411	CcSEcCtD
Testosterone—Diarrhoea—Methotrexate—lymphatic system cancer	7.26e-05	0.000397	CcSEcCtD
Testosterone—Dizziness—Methotrexate—lymphatic system cancer	7.01e-05	0.000384	CcSEcCtD
Testosterone—Vomiting—Methotrexate—lymphatic system cancer	6.74e-05	0.000369	CcSEcCtD
Testosterone—Rash—Methotrexate—lymphatic system cancer	6.69e-05	0.000366	CcSEcCtD
Testosterone—Dermatitis—Methotrexate—lymphatic system cancer	6.68e-05	0.000366	CcSEcCtD
Testosterone—Headache—Methotrexate—lymphatic system cancer	6.64e-05	0.000364	CcSEcCtD
Testosterone—Nausea—Methotrexate—lymphatic system cancer	6.3e-05	0.000345	CcSEcCtD
